MedPath

JONATHAN BERMAN

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Miltefosine Plus IL Pentamidine for Bolivian CL

Phase 2
Completed
Conditions
Leishmaniasis, Cutaneous
Interventions
First Posted Date
2018-02-26
Last Posted Date
2018-02-27
Lead Sponsor
Jonathan Berman
Target Recruit Count
50
Registration Number
NCT03445897
© Copyright 2025. All Rights Reserved by MedPath